Cargando…

Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes

AIM/INTRODUCTION: To investigate the differences in the clinical significance and glutamic acid decarboxylase autoantibody (GADA) affinity between RIA (RIA‐GADA) and ELISA (ELISA‐GADA) in patients with type 1 diabetes. METHODS: A total of 415 patients with type 1 diabetes were enrolled, including 19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawasaki, Eiji, Shimada, Akira, Imagawa, Akihisa, Abiru, Norio, Awata, Takuya, Oikawa, Yoichi, Osawa, Haruhiko, Kawabata, Yumiko, Kozawa, Junji, Kobayashi, Tetsuro, Takahashi, Kazuma, Chujo, Daisuke, Fukui, Tomoyasu, Miura, Junnosuke, Yasuda, Kazuki, Yasuda, Hisafumi, Kajio, Hiroshi, Hanafusa, Toshiaki, Ikegami, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034953/ https://www.ncbi.nlm.nih.gov/pubmed/36691729 http://dx.doi.org/10.1111/jdi.13980

Ejemplares similares

Comparing the clinical significance and antigen specificity of insulinoma‐associated antigen‐2 autoantibodies between radioimmunoassay and enzyme‐linked immunosorbent assay in Japanese patients with type 1 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2022)

Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan
por: Yasui, Junichi, et al.
Publicado: (2016)

Diagnostic criteria for acute‐onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus
por: Kawasaki, Eiji, et al.
Publicado: (2014)

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)
por: Imagawa, Akihisa, et al.
Publicado: (2012)

An Impaired Awareness of Hypoglycemia Improved After Vitamin B(12) Treatment in a Type 1 Diabetic Patient
por: Fujita, Shingo, et al.
Publicado: (2017)

Differences in the Contribution of the CTLA4 Gene to Susceptibility to Fulminant and Type 1A Diabetes in Japanese Patients
por: Kawasaki, Eiji, et al.
Publicado: (2008)

Type 1 Diabetes and Interferon Therapy: A nationwide survey in Japan
por: Nakamura, Kan, et al.
Publicado: (2011)

Poorly controlled type 2 diabetes with no progression of diabetes-related complications and low levels of advanced glycation end products: A Case report
por: Nakamura, Tomoka, et al.
Publicado: (2019)

Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies
por: Tsutsumi, Chiharu, et al.
Publicado: (2011)

T Cell Costimulation by CD6 Is Dependent on Bivalent Binding of a GADS/SLP-76 Complex
por: Breuning, Johannes, et al.
Publicado: (2017)

Complete loss of insulin secretion capacity in type 1A diabetes patients during long‐term follow up
por: Uno, Sae, et al.
Publicado: (2017)

Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient‐derived induced pluripotent stem cells for future research
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

The Dual Role of Scavenger Receptor Class A in Development of Diabetes in Autoimmune NOD Mice
por: Shimizu, Mami, et al.
Publicado: (2014)

Correlation of glycated albumin but not hemoglobin A(1c) with endogenous insulin secretion in fulminant type 1 diabetes mellitus
por: Koga, Masafumi, et al.
Publicado: (2010)

Variants in the BACH2 and CLEC16A gene might be associated with susceptibility to insulin‐triggered type 1 diabetes
por: Onuma, Hiroshi, et al.
Publicado: (2019)

Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes
por: Nakamura, Tomoka, et al.
Publicado: (2023)

Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist: A case report
por: Terakawa, Aiko, et al.
Publicado: (2020)

Endogenous insulin secretion even at a very low level contributes to the stability of blood glucose control in fulminant type 1 diabetes
por: Shibasaki, Saeko, et al.
Publicado: (2010)

High risk of renal dysfunction in patients with fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2017)

Short‐term changes in pancreatic α‐cell function after the onset of fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Durability of Glucose-Lowering Effect of the First Administration of Dulaglutide: A Retrospective, Single-Center, Single-Arm Study
por: Matsushita, Maya, et al.
Publicado: (2018)

Contribution of pancreatic α‐cell function to insulin sensitivity and glycemic variability in patients with type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and Adolescents
por: Delic-Sarac, Marina, et al.
Publicado: (2016)

Adaptation of the brain to hypoglycemia: Does the brain stand by for the next hypoglycemia event?
por: Fukui, Kenji, et al.
Publicado: (2014)

Good MRI images: to Gad or not to Gad?
por: Steen, Henning, et al.
Publicado: (2007)

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
por: Fujishima, Yuya, et al.
Publicado: (2012)

Exenatide Alters Absorption of Hydrocortisone in a Diabetic Patient With Panhypopituitarism: Iatrogenic Adrenal Insufficiency
por: Fujita, Yukari, et al.
Publicado: (2013)

Pseudohypoglycemia or hyperglycemia caused by interference with self‐monitoring blood glucose measurements in anticancer ascorbic acid therapy
por: Kimura, Takekazu, et al.
Publicado: (2013)

Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance
por: Kozawa, Junji, et al.
Publicado: (2012)

Tumor Necrosis Factor-α Promotes Cholestasis-Induced Liver Fibrosis in the Mouse through Tissue Inhibitor of Metalloproteinase-1 Production in Hepatic Stellate Cells
por: Osawa, Yosuke, et al.
Publicado: (2013)

Adiponectin, ALT and family history as critical markers for the development of type 2 diabetes in obese Japanese children
por: Yasuda, Yuki, et al.
Publicado: (2020)

Case of a novel PAX6 mutation with aniridia and insulin‐dependent diabetes mellitus
por: Motoda, Saori, et al.
Publicado: (2018)

Diabetes due to Mitochondrial Adipopathy
por: Ninomiya, Hiroyo, et al.
Publicado: (2017)

Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel α-Cell Model of Insulin-Deficient Diabetes
por: Bessho, Megumi, et al.
Publicado: (2014)

Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?
por: Manto, Mario, et al.
Publicado: (2018)

A Case of Hypogonadotropic Hypogonadism Caused by Opioid Treatment for Nonmalignant Chronic Pain
por: Tabuchi, Yukiko, et al.
Publicado: (2012)

Hyperinsulinemia and Insulin Receptor Gene Mutation in Nonobese Healthy Subjects in Japan
por: Fujita, Shingo, et al.
Publicado: (2017)

Insulin tolerance test predicts the effectiveness of insulin sensitizers in japanese type 2 diabetic patients
por: Kozawa, Junji, et al.
Publicado: (2011)

Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm Study
por: Ueno, Keisuke, et al.
Publicado: (2020)

An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes
por: Jayakrishnan, Bindu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mtj34blp9q54m6fi4liod4b51n